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Summary 
Subcellular, sequence-specific detection of RNA in vivo is a powerful tool to study the 
macromolecular transport that occurs through plasmodesmata. The RNA binding domain of 
Pumilio proteins can be engineered to bind RNA sequences of choice and fused to fluorescent 
proteins for RNA imaging. This chapter describes the construction of a Pumilio-based imaging 
system to track the RNA of Tobacco mosaic virus in vivo, and practical aspects of RNA live-cell 
imaging. 
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1. Introduction 
Plasmodesmata serve as intercellular conduits for different species of RNA between plant cells, 
including siRNAs mediating systemic posttranscriptional silencing (1), miRNAs involved in 
developmental control (2), the infectious genomes of RNA viruses and viroids (3,4), and cellular 
mRNAs (5,6). Therefore, techniques which permit the sequence-specific, dynamic localisation of 
RNAs in live cells are a valuable tool to study plasmodesmata function. A number of such 
techniques are now available (reviewed in (7,8)), but in walled plant cells, non-invasive, 
genetically encoded reporters are most easily applicable. Such systems use sequence-specific 
RNA binding proteins (RBPs) fused to fluorescent proteins (FPs), and are best suited to the 
detection of large RNA species such as viruses and mRNAs. Two classes of RBPs have been 
employed for generally applicable RNA imaging: bacteriophage-derived peptides that recognise 
the secondary structure of specific RNA stem-loops (see chapter by Peña in this volume), and the 
RNA-binding domain of Pumilio proteins. 
Pumilio/FBF family (PUF) proteins are a group of sequence-specific RBPs that are ubiquitous in 
eukaryotes (26 genes in the Arabidopsis genome) and often function as translational repressors 
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(9-13). Their RNA-binding domain, the Pumilio homology domain (PUMHD) has a modular 
structure consisting of eight tandem repeats of a trihelical, 36 amino acid Puf motif. Each of 
these Puf repeats binds one nucleotide (Nt) in an eight-Nt binding motif that has no stable 
secondary structure. All contacts between the PUMHD and RNA are mediated by three amino 
acid side chains per Puf repeat, and the RNA bases. Amino acid side chains in positions 12 and 
16 of each repeat form hydrogen bonds or van der Waals interactions with the Watson-Crick-
edge of the RNA base whilst the side chain of amino acid 13 forms a stacking interaction (14). 
Because only the interactions at position 12 and 16 are base-specific, the sequence-specificity of 
the PUMHD can be modified with just two amino acid modifications per repeat to bind to an RNA 
sequence of choice (14-19). 
To date, only the PUMHD of human Pumilio1 (HsPUM1-HD) has been used for RNA imaging, but 
in the future, PUMHDs derived from other PUF proteins may emerge as valuable alternatives and 
broaden the range of imaging possibilities. Pumilio-based RNA imaging has enabled subcellular 
detection of the mRNAs of mitochondrial NADH dehydrogenase and -actin, as well as retroviral 
RNA in mammalian cultured cells (20-23), and of the genomes of Tobacco mosaic virus, Potato 
virus X and Turnip mosaic virus in live plant tissue (24-27). Of particular relevance to the topic of 
this volume, Pumilio-based RNA imaging has recently shown that Potato virus X is present in 
membrane structures at the entrances of plasmodesmata that also contain the viral replicase 
(27). 
The advantages of using modified PUMHDs for RNA imaging are 1) untagged, native RNA species 
expressed from their native genomic context can be localised (20,21,24), avoiding both the need 
to modify the RNA and to introduce expression constructs into the genome; 2) if instead PUMHD 
recognition sequences are engineered into an RNA as a tag, no extensive secondary structures 
are introduced which might affect RNA function and localisation (though the PUMHD can 
actually access substantially structured target motifs (18)); 3) PUMHD variants can have 10- to 
100-fold higher RNA affinities than stem-loop binding peptides used in alternative RNA imaging 
systems, thus PUMHD-based imaging is potentially more sensitive. 
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On the other hand, PUMHD RNA recognition has a degree of promiscuity (28,29), and eukaryotic 
cells contain mRNA targets of native Pumilio proteins. Therefore, all Pumilio-based RNA imaging 
approaches use two PUMHD variants binding to the same target RNA to increase overall 
specificity and RNA affinity (20,30). In the future, artificial PUMHDs with more than eight 
repeats that recognise longer target sequences may further improve the specificity of Pumilio-
based RNA imaging (18,30). 
The adjustable sequence specificity of the PUMHD requires re-design and optimisation of 
Pumilio-based RNA imaging systems for any RNA of interest. Therefore, in the following 
paragraphs the considerations that have to be made when designing a PUMHD-based reporter 
system for a new RNA of interest are discussed, before providing a detailed protocol for imaging 
a specific RNA, that of Tobacco mosaic virus (TMV). 
 
1.1. Choice of reporter system 
When using any RBP-FP fusion for RNA imaging, it is necessary to distinguish between the RNA-
bound and free states of the reporter, i.e. RNA-dependent signal and RNA-independent 
background. For PUMHD-based reporters, three different approaches have been used to identify 
RNA-bound fluorescence (Fig. 1). All systems use two PUMHD variants. 
Nuclear targeting of a permanently fluorescent pair of fused PUMHDs (Fig. 1A) leads to 
confinement of fluorescence in the nucleus in the absence of target RNA. If the reporter is co-
exported from the nucleus with a bound RNA, or binds to cytoplasmic RNA after translation, 
cytoplasmic fluorescence reveals the RNA’s location. This approach is routinely used in RNA 
imaging with stem-loop binding bacteriophage peptides (see chapter by Peña in this volume). 
Attempts to apply the same principle to PUMHD-based imaging with two directly coupled 
PUMHDs fused to an FP and nuclear localisation signal (NLS) at their N-terminus (NLS-FP-
PUMHD-PUMHD) proved unfeasible in plant cells because the reporter aggregated in the nucleus 
(unpublished data). However, a fusion with the FP inserted between the PUMHDs (NLS-PUMHD-
FP-PUMHD) was recently used in mammalian cells (23) and may also work in plants. 
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Alternatively, the two PUMHD variants can be fused separately to two halves of a split FP, so that 
when both fusion proteins bind to the same target RNA, the split FP halves come into close 
proximity and re-fold into the complete FP, resulting in bimolecular fluorescence 
complementation (PUM-BiFC) at the location of the RNA (20,24) (Fig 1B). This principle is the 
only form of Pumilio-based RNA imaging so far applied in plants (24-27). 
Unfortunately, PUM-BiFC is not background-free. In BiFC, the fluorescent complex of N- and C-
terminal split FP halves is extremely stable (31). As the BiFC constructs accumulate in a cell, the 
increasing frequency of random collisions will result in the formation of low levels of 
reassembled FP, independent of interactions of fused PUMHDs with their cognate RNA. 
Additionally, due to their stability, PUM-BiFC complexes formed on the target RNA can dissociate 
from the RNA without ‘switching off’. Both of these processes lead to the gradual accumulation 
of false-positive signal and thus reduce the signal-to-noise ratio. RNA-dependent PUM-BiFC 
signal has to be distinguished from this background by relative fluorescence levels and 
localisation (see 3.3.). An additional side-effect of RNA-independent formation of PUM-BiFC 
complexes is that these pre-formed complexes can be recruited to the target RNA by the 
interaction of only one of the two PUMHDs. Thus, RNAs can be imaged with only a single binding 
site (24,25) or when the orientation of PUMHD fusions would be expected to prevent proximity 
of split FP halves after RNA binding (see below) (22). Whilst this may sometimes be useful, it is 
not generally desirable, as it reduces the overall specificity of the PUM-BiFC system and 
eliminates the benefits of using two RNA binding domains. 
Several recently developed approaches that improve the signal-to-noise ratio of BiFC by 
introducing further modifications into the split FP fragments (31,32) are still unexplored for 
PUM-BiFC applications. Also, a tetramolecular fluorescence complementation system for 
Pumilio-based RNA detection was recently introduced (PUM-TetFC) (33) (Fig. 1C) which has a 
very high signal-to-noise ratio in vitro, but is still untested in vivo. In PUM-TetFC, superfolder 
GFP is split into three fragments, the main -barrel containing -sheets 1-9, and the isolated -
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sheets 10 and 11, which are fused to the two PUMHD variants (the fourth component of TetFC is 
the RNA). 
In the protocol following below, I describe the construction of a PUM-BiFC system as this is the 
only Pumilio-based approach so far used successfully in plants. However, as fluorescence 
complementation techniques are being continuously improved, it is recommended to consult 
relevant recent literature before constructing a novel PUM-BiFC system. 
 
1.1.1. Choice of FP: 
BiFC can be performed with various derivatives of both GFP and red FPs (31,34-39). This allows 
selection of an FP that will facilitate co-localising the RNA of interest with other fluorescent 
markers that may already be available. In practice, only the GFP-derivatives EGFP, Venus and 
mCitrine have so far been used for PUM-BiFC, and of these, only PUMHD-split-mCitrine fusions 
in plants (20,24). PUMHD fusions with split-mRFP1(Q66T) (40) failed to produce fluorescence in 
preliminary experiments (unpublished data). 
 
1.1.2. Choice of FP splitting position: 
Commonly, FPs are split either between -sheets 7 and 8 (amino acids 154/155 or 157/158) or 
between -sheets 8 and 9 (amino acids 172/173) (31,34). Both have been employed in PUM-
BiFC (EGFP, Venus split at 157/158 (20), mCitrine split at 172/173 (24)). As it is the only PUM-
BiFC system used in plants so far, fusions with mCitrine split between amino acids 172/173 are 
recommended until other split FPs have been tested. 
 
1.1.3.Orientation of PUMHD-split FP fusions: 
The PUMHD interacts with RNA in an antiparallel orientation, i.e. the N terminus is oriented 
towards the 3’ and the C terminus towards the 5’ end of the target sequence (Fig. 2). This means 
that the N terminus of the upstream and the C terminus of the downstream binding PUMHD will 
be in proximity to each other and have to be fused to the split FP halves. Fusing FP fragments at 
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the opposite ends (C terminus of upstream and N terminus of downstream PUMHD) prevents 
fluorescence complementation (33). This leaves two possible choices of fusion orientations: if 
PUMHDs are fused to the N terminus of the FPN and the C terminus of the FPC fragment, they are 
attached to the natural termini of the FP. If PUMHDs are fused to the C terminus of FPN and the 
N terminus of FPC, they are attached to the rim of the FP -barrel, with splitting positions 
between -sheets 7 and 8 or 8 and 9 resulting in fusions to opposite rims of the -barrel. Both 
configurations are possible and allow fluorescence complementation. Thus, the constraints 
imposed by the structures of both the PUMHD and the FP allow for two possible fusion 
combinations: FPC-PUMHDupstream + PUMHDdownstream-FPN, or FPN-PUMHDupstream + 
PUMHDdownstream-FPC. Only the latter combination has so far been used in RNA imaging and is 
therefore the recommended option (20,21,24,33). 
 
1.2. Choice of target sequences and PUMHD variants 
PUM-BiFC imaging can be used in two different modes: PUMHDs can be modified to bind to the 
native RNA of interest (20,21,23-25), or the RNA can be tagged with recognition motifs of 
previously characterised PUMHD variants (22,24,26,27,33) (Table 1). As described in the 
introduction, leaving the RNA unmodified has the advantage of avoiding potential RNA 
processing and localisation artefacts that could be caused by a tag, and by the expression of the 
tagged construct from an artificial genomic context. The latter is mainly a concern with nuclear 
mRNAs, not viruses. On the other hand, suitable binding sites that can be easily targeted with a 
limited number of PUMHD modifications may not be present in the RNA of interest, and whilst 
the binding specificity of modified PUMHDs can be predicted, it is harder to predict effects of 
modifications on RNA affinity, binding promiscuity, and protein solubility and stability (15). 
Such potential problems can be avoided by using an RNA tag recognised by previously 
characterised PUMHD variants (Table 1), which can also increase specificity. For instance, 
Kellermann et al. (33) used a combination of wild-type PUMHD and Mut6-2/7-2 because these 
bind to their cognate targets with high affinities, but have low affinities for the binding sites of 
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the respective other variant (15). The choice between modifying PUMHD variants or tagging the 
RNA will thus depend on considerations of the available target sequences and the suitability of 
previously characterised PUMHD variants for any given RNA. 
Analyse the RNA of interest for the presence of sequences with similarity to native Pumilio 
binding sites. The target sequence of wild-type HsPUM1-HD is UGUANAUA (N = A, U, or C) 
(29,41) (Fig. 2) and most PUMHDs bind to sequences starting with a 5’UGU triplet (29). This 
sequence motif is thus a good starting point for the identification of suitable target sequences. 
However, PUMHD variants with altered specificity of Puf repeats 6-8 (Table 1), which bind to 
the triplet, have also been used for RNA imaging and detection (20,24,33). Plant RNA virus 
genomes often contain native Pumilio binding sites that can be exploited for PUM-BiFC imaging 
(and may be targets of native Pumilio proteins involved in host defense responses) 
(24,25,42,43). 
The two target sites should be closely adjacent, but separated by a short linker region to prevent 
steric hindrance of two simultaneously binding PUMHD fusions. With PUM-BiFC, dual target 
sites separated by linkers between 5 and 11 nucleotides long have been successfully imaged (20-
22,24) (but see Note 1). 
So far, modified PUMHD variants with up to five altered base specificities have been used for 
RNA imaging (20,24), and with up to seven modified Puf repeats in engineered splicing factors 
(19). However, with increasing numbers of amino acid changes, effects on overall RNA affinity 
and protein folding become more unpredictable. 
If no suitable binding sites can be identified or very extensive PUMHD modifications would be 
required, and if no disadvantages from tagging the RNA are expected, select suitable previously 
described PUMHD variants, e.g. wild-type and mut6-2/7-2 PUMHD (33), to design an RNA tag. In 
order to not disrupt open reading frames, RNA tags have to be inserted into untranslated 
regions. A good starting point is to introduce the tag directly downstream of an ORF immediately 
after the stop codon. Tagging upstream of the start codon may also work, and in some cases, 
several options may have to be tested (24,44). 
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Table 1 lists previously characterised modified PUMHD variants ordered by alterations in their 
recognition sites from 5‘ to 3’, to facilitate easier selection of RNA target sites or tags. After 
selection of target sites or tags, the wild-type HsPUM1-HD needs to be modified into two 
different variants to bind the selected sequences. The molecular code for base-specificity of Puf 
repeats is as follows (15,16,18,19,30,45): 
C/SXXXQ = A 
NXXXQ = U 
SXXXE = G 
S/T/G/C/AXXXR = C 
where the letters represent amino acids 12-16 of each Puf repeat, and X in positions 13-15 are 
amino acids not involved in base specificity. In the HsPUM1 ORF, the relevant amino acids 
corresponding to residues 12 and 16 in each repeat, respectively, are: Puf1 [863, 867]; Puf2 
[899, 903]; Puf3 [935, 939]; Puf4 [971, 975]; Puf5 [1007, 1011]; Puf6 [1043, 1047]; Puf7 [1079, 
1083]; Puf8 [1122, 1126] (Table 1). The italicised residue 971 in Puf4 does not actually 
participate in RNA interactions (14,15)). The amino acids in position 13, which contribute 
stacking interactions to RNA binding, are left unchanged (see Note 2). Avoid using Puf4/Nt5 
modifications as a main specificity determinant (see Note 3). 
 
1.3. Choice of expression system 
In principle, PUM-BiFC reporter constructs can be stably expressed, but so far all Pumilio-based 
RNA imaging in plants has been done with transient expression systems (agroinfiltration or 
microprojectile bombardment) (24-27). Since nonspecific background fluorescence increases 
with the accumulation of the PUM-BiFC fusions, transient expression may be preferable as it 
permits limiting background fluorescence by reducing the expression time (see 3.3.). 
Agroinfiltration is generally preferable to biolistic bombardment, as it leads to reporter 
expression in large tissue areas, and makes it easier to assess cell-to-cell variability of PUM-BiFC 
signal and find optimal imaging conditions (see 3.3.). It is therefore recommended to use 
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agroinfiltration as the first choice of expression system. However, when viral RNAs are imaged, 
co-expression of agrobacterium-delivered plasmids and virus can be problematic and in that 
case, bombardment provides a useful alternative means of delivering reporter constructs. 
 
After these general considerations, the following protocol describes the construction of a PUM-
BiFC system to image the untagged, genomic RNA of Tobacco mosaic virus (TMV) (24,26). 
 
2. Materials 
1. A plasmid containing a HsPUM1-HD ORF (encoding amino acids Gly828-Gly1176 of the 
full-length HsPUM1 protein) as a PCR template (available from 
www.openbiosystems.com). 
2. A plasmid containing a Citrine fluorescent protein ORF as a PCR template, e.g. pSAT6-
Citrine-N1 (GeneBank acc. AY818369) (46). 
3. Primers (see Table 2). 
4. Standard molecular cloning materials: Commercial kits for high-fidelity PCR 
amplification, PCR clean up, DNA gel extraction, and plasmid minipreps; PCR machine; 
gel chamber and power supply for running horizontal agarose gels; benchtop 
centrifuges; electrocompetent E.coli cells, e.g. strain DH5, and electroporator; LB media 
(liquid and agar plates) containing either 50 g/ml gentamicin or 100 g/ml 
spectinomycin; 37C shaking and non-shaking incubators. 
5. GatewayTM vectors pDONR207 (LifeTechnologies) and pGWB402Ω (47). 
6. GatewayTM BP and LR Clonase (LifeTechnologies). 
7. Electrocompetent Agrobacterium tumefaciens cells, strain AGL1; LB media (liquid and 
agar plates) containing either 100 g/ml spectinomycin and 50 g/ml rifampicin; 28C 
shaking and non-shaking incubators. 
8. Infiltration medium:10 mM MES pH 5.6, 10 mM MgCl2, 15 M acetosyringone. 
9. Spectrophotometer for measuring optical density at 600 nm (OD600). 
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10. Gauge 25 needles. 
11. 1 ml syringes. 
12. 3-4 weeks old Nicotiana benthamiana plants. 
13. An infectious clone of TMV which must contain nucleotides 3794-3816 (within the 183k 
RNA polymerase domain), e.g. TMV.DsRed (24). 
14. A commercial kit for RNA in vitro transcription with an RNA polymerase matching the 
infectious TMV construct (T7 for TMV.DsRed). 
15. Aluminium oxide powder. 
16. A confocal laser-scanning microscope equipped with 514 and 561 nm excitation light 
sources and suitable detection systems for mCitrine and mRFP. An upright microscope 
equipped with water-dipping lenses is the preferable setup for imaging intact plant 
tissue in vivo. 
 
3. Methods 
3.1. Modification of PUMHDs 
To direct one PUMHD variant (PUMHD3794) to bind to the sequence UGUAGAUA (nucleotides 
3794-3801 of the TMV genome), the specificity of Puf4 needs to be modified (U5G: 
N971S/H972N/Q975E). A second PUMHD variant (PUMHD3809) is engineered to bind the 
sequence UGAUAGUU (nucleotides 3809-3816 of TMV) by altering the specificities of Puf1 (A8U: 
S863N), 3 (A6G: C935S/Q939E), 4 (U5A: N971C), 5 (A4U: C1007N), and 6 (U3A: N1043C). 
1. PUMHD3794 (see Fig. 3A for schematic of the construction process and finished fusion 
construct): 
PCR#1:Amplify an N-terminal fragment of PUMHD3794 from a wild-type PUMHD 
template using primer pair link-PUMfor/U5G_441rev (see Table 1 for all primer 
sequences used in this protocol. All primers are designed for annealing at 55C).  Use a 
proof-reading, high fidelity polymerase according to manufacturer’s instructions, but 
amplify for only 10 cycles to minimize the likelihood of PCR errors. The link-PUMfor 
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primer adds the flexible GGGGS linker that will connect the PUMHD to the N-terminal 
mCitrine fragment (see below) and a unique XbaI site for easy exchange of PUMHD 
variants.  
2. Gel-purify the ~0.4 kb PCR product on a 2% agarose gel using a commercial gel 
extraction kit. The PCR product will serve as the template in the next PCR reaction and 
gel purification removes the wild-type PUMHD template that would otherwise be 
amplified in the next PCR. 
3. PCR#2: Amplify the purified N-terminal PUMHD fragment again, this time with primers 
link-PUMfor/U5G_449rev and again using only 10 PCR cycles. 
4. PCR#3: From the wild-type PUMHD template, amplify a ~0.6 kb C-terminal fragment of 
PUMHD3794 using primers U5G_434for/attB-PUMrev (10 cycles only). Gel-purify the 
product as above. The attB-PUMrev primer adds a Gateway attB2 anchor as well as a 
unique XhoI site for easy exchange of PUMHD variants. 
5. PCR#4: Amplify the C-terminal fragment again using primers U5G_425for/attB-PUMrev 
(10 cycles). 
6. PCR#5 (overlap PCR of full-length PUMHD3794): The four U5G primers have introduced 
all three required point mutations and also created a 25 bp overlap between the N- and 
C-terminal fragments. Using the products of PCR#2 and #4 as templates, amplify the 
~1.05 kb full-length PUMHD3794 using primers link-PUMfor/attB-PUMrev with 10 PCR 
cycles. 
7. PUMHD3809 (see Fig. 3B): 
The multiple mutations introduced in this PUMHD variant require a multi-step overlap 
PCR. As above, use a high-fidelity polymerase and only 10 PCR cycles for each PUMHD 
fragment. All PCR products amplified from wild-type template need to be gel-purified 
before proceeding to subsequent overlap PCR steps. 
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8. PCR#1: Amplify an N-terminal 0.12 kb fragment of PUMHD3809 using primers attB-
PUMfor/A8U_119rev. Gel-purify. The attB-PUMfor primer adds a Gateway attB1 anchor, 
as well as a unique XbaI site for easy exchange of PUMHD variants. 
9. PCR#2: Amplify a ~0.2 kb fragment from bp 95-333 of PUMHD3809 using primers 
A8U_095for/A6G_333rev1. Gel-purify. 
10. PCR#3: Extend PCR#2 product by amplification with primers A8U_095for/A6G_333rev2. 
11. PCR#4: Amplify a 0.12 kb fragment from bp 323-440 of PUMHD3809 using primers 
A6G_323for/U5A_440rev. Gel-purify. 
12. PCR#5: Amplify a 0.32 kb overlap-product from bp 95-440 of PUMHD3809 using both 
PCR#3 and PCR#4 products as templates and primers A8U_095for/U5A_440rev. 
13. PCR#6: Amplify a 0.44 kb overlap product from bp 1-440 of PUMHD3809 using both 
PCR#1 and PCR#5 products as templates, and primers attB-PUMfor/U5A_440rev. 
14. PCR#7: Amplify a ~0.13 kb fragment from bp 416-549 of PUMHD3809 using primers 
U5A_416for/A4U_549rev. Gel-purify. 
15. PCR#8: Amplify a 0.55 kb overlap product from bp 1-549 of PUMHD3809 using both 
PCR#6 and PCR#7 products as templates, and primers attB-PUMfor/A4U_549rev. 
16. PCR#9: Amplify a ~0.13 kb fragment from bp 527-658 of PUMHD3809 using primers 
A4U_527for/U3A_658rev. Gel-purify. 
17. PCR#10: Amplify a 0.66 kb overlap product from bp 1-658 of PUMHD3809 using both 
PCR#8 and PCR#9 products as templates, and primers attB-PUMfor/U3A_658rev. 
18. PCR#11: Amplify a ~0.43 kb C-terminal fragment of PUMHD3809 using primers 
U3A_625for/link-PUMrev. Gel-purify. The link-PUMrev primer extends the PUMHD with 
the flexible GGGGS linker that will connect it to the C-terminal fragment of mCitrine (see 
below) and also adds a unique XhoI site for easy exchange of PUMHD variants. 
19. PCR#12 (overlap PCR of full-length PUMHD3809): Amplify ~1.05 kb full-length 
PUMHD3809 using both PCR#10 and PCR#11 products as templates, and primers attB-
PUMfor/link-PUMrev. 
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3.2. Construction of PUMHD-split mCitrine fusions 
1. Amplify the 0.52 kb N-terminal fragment of Citrine fluorescent protein (CitN; amino 
acids 1-172) using a plasmid encoding Citrine (e.g. pSAT-Citrine-N1 (46)) as the 
template, and primers attB-Citfor/link-CitNrev (high-fidelity polymerase, 10 PCR cycles). 
The attB-Citfor primers adds a Gateway attB1 anchor, while the link-CitNrev primer adds 
the GGGGS linker for connection to PUMHD3794.  
2. Amplify a C-terminal fragment of Citrine (mCitC; amino acids 173-239) in an overlap 
PCR that introduces the A206K mutation which prevents dimerization of GFP and its 
derivatives (48,49): Amplify two ~0.1 kb fragments in separate PCRs using primers link-
CitCfor/Citmonorev and Citmonofor/attB-Citrev, respectively, from a Citrine-encoding 
plasmid (high-fidelity polymerase, 10 cycles). The link-CitCfor primer adds the GGGGS 
linker that will connect to PUMHD3809. The attB-Citrev primer adds a Gateway attB2 
anchor. After gel-purification, amplify the complete C-terminal fragment of 
monomerized Citrine (mCitC) using both partial PCR products as templates, and primers 
link-CitCfor/attB-Citrev (10 cycles). 
3. Amplify the complete CitN-PUMHD3794 fusion using CitN and full-length PUMHD3794 
PCR products as templates, and primers attB1-adapter/attB2-adapter. Use a high-fidelity 
polymerase and 20 PCR cycles. Run a 5 l aliquot of the PCR reaction on a 1% agarose 
gel. If there is a single, 1.6 kb product, remove remnants of the PCR reaction using a 
commercial PCR clean up kit. If more than one PCR product was obtained, run the rest of 
the PCR out on the gel, and excise and gel-purify the 1.6 kb band using a commercial kit. 
4. Amplify the complete PUMHD3809-mCitC fusion using full-length PUMHD3809 and 
mCitC PCR products as templates, and primers attB1-adapter/attB2-adapter. Use a high-
fidelity polymerase and 20 PCR cycles. Run a 5 l aliquot of the PCR reaction on a 1% 
agarose gel. If there is a single, 1.3 kb product, remove remnants of the PCR reaction 
using a commercial PCR clean up kit. If more than one PCR product was obtained, run the 
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rest of the PCR out on the gel, and excise and gel-purify the 1.3 kb band using a 
commercial kit. 
5. Recombine both CitN-PUMHD3795 and PUMHD3809-mCitC products into a Gateway 
DONR vector, e.g. pDONR207 (GentR), using GatewayTM BP recombinase 
(LifeTechnologies) according to manufacturer’s instructions. Transform the BP 
recombination into E.coli competent cells and plate on LB agar containing 50 g/ml 
gentamicin. On the next day, pick several colonies for overnight culture in LB liquid 
media containing gentamicin, then isolate the plasmids using a commercial kit. Verify 
that the mCitN-PUMHD3794 and PUMHD3809-CitC fusions have no PCR errors by 
sequencing the DONR vector inserts. 
6. Recombine error-free fusion constructs into a Gateway destination binary vector for 
plant expression, e.g. pGWB402Ω (SpecR; (46)), using GatewayTM LR Clonase 
(LifeTechnologies) according to manufacturer’s instructions. Transform the LR reaction 
into E. coli competent cells and plate on LB agar containing 100 g/ml spectinomycin. On 
the next day, pick several colonies for overnight culture in LB liquid media containing 
spectinomycin, then isolate the plasmids using a commercial kit. Check that correct 
expression constructs were obtained by diagnostic restriction digest (e.g. excising the 
~1.05 kb PUMHD using XbaI/XhoI). 
3.3. PUM-BiFC in vivo imaging 
1. Transform CitN-PUMHD3794 and PUMHD3809-mCitC binary expression vectors 
separately into electrocompetent Agrobacterium tumefaciens cells strain AGL1 (other 
strains are also suitable). Plate the transformed agrobacteria on LB agar containing 100 
g/ml spectinomycin to select for transformants, and 50 g/ml rifampicin to suppress 
growth of other bacteria. Grow plates at 28C for two days. 
2. Transcribe TMV.DsRed (24) RNA in vitro, using a commercial T7 polymerase kit 
according to manufacturer’s instructions. Keep the RNA on ice after transcription. Infect 
3-4 weeks old Nicotiana benthamiana plants by dusting the leaves thinly with aluminium 
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oxide power and then gently rub-inoculating 5-10 l transcript with a gloved hand (see 
Note 4). Incubate plants at 33C after infection. 
3. Two days after infection, pick single colonies into 4 ml liquid LB media containing 
spectinomycin and rifampicin and grow in a shaking incubator at 28C for two days (see 
Note 5). 
4. Pellet the bacterial cultures, then resuspend each pellet into 2 ml infiltration medium. 
5. Incubate the resuspended agrobacteria at room temperature in the dark for about 1 h, 
then measure the OD600. 
6. Mix and dilute CitN-PUMHD3794 and PUMHD3809-mCitC-containing agrobacteria with 
infiltration medium so that both are present at OD600 = 0.25 in the final mixture (i.e. total 
combined OD600 = 0.5). 
7. With the tip of a needle, create small incisions on the abaxial (lower) side of uninfected 
and TMV-infected Nicotiana benthamina leaves by gently touching the leaf surface with 
the needle so that a dark point is just visible. 
8. Carefully infiltrate the agrobacterium mixture into these incisions using a 1 ml syringe 
without a needle pressed on the incision site (see Note 6). Ca. 1-2 ml of suspension are 
required to cover a leaf. Agrobacteria can be infiltrated in patches, e.g. overlapping with 
virus-infected issue areas, or into the entire leaf lamina, depending on experimental 
requirements. 
9. For imaging, place whole or half leaves or ~2 x 2 cm leaf pieces under a microscope lens 
by fixing them to a microscope slide using double-sided sticky tape, with the lower 
epidermis facing up. An upright microscope with water-dipping lenses, which can be 
directly immersed in a drop of water placed on the leaf with no cover glass in between, is 
ideal for plant imaging. Excite mCitrine BiFC at 514 nm and detect mCitrine fluorescence 
at 520-550 nm. Excite DsRed at 561 nm and detect DsRed fluorescence at 570-600 nm.  
10. Begin imaging by monitoring the level and localisation of background fluorescence in 
uninfected tissue every day from 1-4 days post infiltration (dpi). (See Note 7). Expect 
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false-positive BiFC fluorescence to be distributed fairly homogenously throughout the 
nucleoplasm and cytoplasm. The nucleus tends to be brighter than the cytoplasm. At 
very high expression levels or in small cells, PUM-BiFC may aggregate. 
11. In parallel to uninfected control plants, image the PUM-BiFC reporter constructs in TMV-
infected tissue, also daily from 1-4 dpi (corresponding to 5-8 days after TMV infection). 
Compared to the negative control, expect increased fluorescence intensity (see Note 8), 
and also a re-localisation. In particular, nucleoplasmic signal usually disappears in the 
presence of target RNA and instead of general cytoplasmic fluorescence, the PUM-BiFC 
signal is expected to be concentrated in granular viral replication sites which can be 
small and dispersed in the cytoplasm, or aggregated into a large perinuclear inclusion 
body (24,25) (Fig. 4).  
12. Monitoring BiFC for several days after infiltration and comparing the signal intensity and 
localization in uninfected and infected tissue establishes a suitable time window for 
obtaining a good signal-to-noise ratio  (see Note 9). Once this has been accomplished, the 
time span separating infection and reporter infiltration can be varied (see step 3 above) 
to follow the TMV RNA localisation throughout the infection cycle (see Note 10). 
 
4. Notes 
1. Kellermann et al. (33) found that a 7 nucleotides long linker between PUMHD binding 
sites was optimal for PUM-TetFC, and de- or increasing it to 5 or 9 nucleotides, 
respectively, significantly reduced the fluorescent signal. The length of a suitable linker 
will depend on the length and flexibility of the protein linker between PUMHD and FP 
fragment, but it should be kept in mind that the greater tolerance of PUM-BiFC for 
different linker lengths may actually be due to recruitment of pre-formed PUM-BiFC 
complexes to the RNA by just one of the two PUMHDs (see 1.1.). In PUM-BiFC systems 
with improved signal-to-noise ratio, linker length may become more critical and may 
have to be empirically optimised. 
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2. Amino acid residues that participate in stacking interactions with the RNA bases can also 
contribute to base specificity, and their modification can either increase or decrease 
binding promiscuity (19,50). However, modifying these residues can also negatively 
affect overall RNA affinity and protein solubility (15,50). Therefore, until a systematic 
investigation has led to a detailed understanding of stacking interactions in HsPUM1-HD, 
it is recommended that amino acids at position 13 of the Puf repeats are not modified. 
3. Note that Puf4 in the wild-type PUMHD can promiscuously bind any base at position 5 
(29). Puf4 differs slightly from the other Puf repeats in that its Asn971 in position 12 
does not contact the RNA base, whereas Gln975 can interact either with the Watson-
Crick edge of U, the Hoogsteen edge of A or G, or not contact the base at all when a C is in 
position 5. Whilst binding specificity of Puf4 can be modified, the fifth base of target 
sequences should therefore not be used as a critical specificity determinant, e.g. as the 
only difference between two target sites. 
Position 8, bound by Puf1 also shows some promiscuity and can accept G instead of A 
(15), whilst other promiscuous binding modes of Puf3 and 7 have lower affinities for 
non-cognate bases but these may still be in a range that permits binding during RNA 
imaging in vivo (15,20). Lastly HsPUM1-HD can bind 9 nucleotide sequences by flipping 
one base out away from the protein surface (28). It is useful to be aware of these 
alternative binding modes when choosing target sites for imaging and creating modified 
PUMHD variants. 
4. The infectious TMV clone does not have to express a fluorescent protein, but this helps to 
identify infected leaf areas. Encapsidating transcribed RNA into TMV capsid protein in 
vitro, passaging TMV from infectious lesions, or expressing the TMV genome in planta 
from a CaMV 35S promoter (e.g. pTRBO; (51)) following either DNA rub-inoculation, 
microprojectile bombardment, or agroinfiltration are also suitable methods of infection. 
5. It is useful to make glycerol stocks of transformed agrobacteria to save time when 
repeatedly growing liquid cultures for imaging. 
 19 
6. Young leaves are easier to infiltrate as they have larger airspaces. Avoid pressing the 
opening on the syringe too hard onto the leaf surface as this will cause extensive damage. 
Also, if air spaces in the mesophyll are tight causing a high resistance to the infiltration, 
increasing the injection pressure is more likely to cause agrobacterium mixture to squirt 
out sideways from under the rim of the syringe than to improve infiltration.  
7. Since folding and stability of split FP fragments are influenced by fusion partners such as 
the PUMHD variants (which may themselves differ in their respective in vivo folding 
efficiency and stability), unfused split FP halves are no suitable negative control in BiFC. 
Ideal BiFC controls are fusions with non-interacting variants of the proteins used in the 
actual experiments (31). In the case of PUM-BiFC this corresponds to either the absence 
of the target RNA as described here, or PUMHD fusions that do not bind the target RNA 
(24,33). Background fluorescence due to random collisions should be the same for both 
types of controls. However, the ability to bind cellular RNAs promiscuously, as well as 
the folding efficiency and stability of the PUMHD-split FP fusions may differ for different 
pairs of PUMHDs. Therefore, expressing the target RNA-specific reporter constructs in 
the absence of the target provides the best negative control. 
8. Make sure not to oversaturate images during acquisition. Differences in fluorescence 
intensity between infected cells and uninfected controls are only apparent when images 
are not overexposed. Try to work at the lowest possible gain settings to maximise the 
contrast. 
9. A direct comparison between nonspecific and TMV-dependent BiFC levels may be 
difficult because viruses often suppress other ectopic expression constructs to a 
considerable degree. It may be necessary to increase OD600 and expression time for 
infected tissue compared with the negative control. 
10. PUM-BiFC expression levels may need to be re-optimised when imaging different 
infection stages. In strongly infected tissue at late infection stages, expression of the RNA 
reporter constructs may be too strongly suppressed to produce sufficient PUM-BiFC 
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signal for imaging. Conversely at early infection stages, if PUM-BiFC accumulates too 
much compared to viral RNA levels, the signal-to-noise ratio will be too low to clearly 
localise the viral RNA over the background. 
To compensate for such effects, PUMHD fusion constructs can be agroinfiltrated at an 
OD600 between ~0.1 and 1.0 each (at a 1:1 ratio). It may also be worth experimenting 
with unequal expression ratios to optimise the signal-to-noise ratio and minimize 
aggregation (24). 
Even after optimisation of imaging conditions, expression levels are usually very 
heterogenous throughout the tissue and across viral lesions. The number of cells that 
have an optimal virus/PUM-BiFC ratio at a specific viral infection stage may be very 
small in a single experiment. It is therefore important to observe large areas of tissue 
and repeat experiments to both find suitable imaging conditions and ensure their 
reproducibility. 
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Figure Captions 
Figure 1. Methods to distinguish RNA-bound and unbound PUMHD reporters. A. Relocalisation 
of a nuclear-targeted, permanently fluorescent double-PUMHD fusion to the cytoplasm in the 
presence of target RNA (23). B. Assembly of a bimolecular fluorescence complementation 
complex on the target RNA (PUM-BiFC) (20). This is the approach described in this protocol. C. 
Assembly of a tetramolecular fluorescence complementation complex on the target RNA (PUM-
TetFC) (33). 
 
Figure 2. Base-specific interactions between the HsPUM1-HD and its target sequence. Dotted 
lines represent hydrogen bonds and parentheses represent van der Waals contacts. Modified 
from (14,15). 
 
Figure 3. Construction schematics and finished PUMDH-split mCitrine fusions for TMV imaging. 
A. CitN-PUMHD3794. B. PUMHD3809-mCitC. 
  
Figure 4. Example of TMV RNA imaged with the PUM-BiFC system. Viral RNA is visible in small 
punctae dispersed throughout the cytoplasm and a large perinuclear inclusion body (arrow). N: 
nucleus. Scale bar: 50 m. 
  
Table Captions 
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Table 1. RNA-contacting amino acid residues and cognate targets of HsPUM1-HD variants. For 
each variant, Puf repeats from Puf8 to Puf1 (C- to N-terminal direction) and RNA sequences in 
5’-3’ orientation are shown from left to right in each row; amino acid residues 16, 13, and 12 are 
shown from top to bottom in each column. PUMHD variants are listed in order of changes to the 
target sequence specificity in 5’ to 3’ direction. Changes in amino acids and RNA targets are 
highlighted in bold and shaded. Italicised N971 does not contribute to RNA contacts in HsPUM1-
HD. Where absolute dissociation constants have been determined for the shown target 
sequence, these are listed (n.d.: not determined). Note that dissociation constants for 
promiscuously bound alternate target sequences are not shown. These are always higher than 
for the main target, but may well be in a range suitable for RNA imaging purposes (refer to 
original publications for alternative kD’s and relative binding activities of individual PUMHD 
variants, in particular (15)). 
 
Table 2. Primers required for construction of a PUM-BiFC system to image untagged TMV RNA 
in vivo. XbaI and XhoI restriction sites are underlined, mutagenic nucleotides highlighted by 
boldface font and shading. 
 
Table 1: Modified HsPUM1-HD variants 
PUMHD Puf8 Puf7 Puf6 Puf5 Puf4 Puf3 Puf2 Puf1 References 
wild-type Q1126 E1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (14,22,24,2
5,33,53) Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 C935 N899 S863 
kD = 0.5 nM U G U A U/C A U A 
          
U1C R1126 E1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 G1122 S1079 N1043 C1007 N971 C935 N899 S863 
kD n.d. C G U A U/C A U A 
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PUF#2 R1126 Q1083 E1047 Q1011 Q975 Q939 R903 Q867 (19) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 S1122 N1079 S1043 C1007 N971 C935 S899 S863 
kD n.d. C U G A U/C A C A 
          
PUF-E E1126 R1083 Q1047 E1011 Q975 Q939 E903 R867 (19) 
Y1123 Y1080 Y1044 R1008 H972 R936 Y900 Y864 
 S1122 S1079 N1043 S1007 N971 N935 S899 S863 
kD n.d. G C U G U/C U G C 
          
PUF#1 E1126 R1083 E1047 E1011 Q975 E939 Q903 E867 (19) 
Y1123 Y1080 Y1044 R1008 H972 R936 Y900 R864 
 S1122 S1079 S1043 S1007 N971 S935 
C/S 
899 S863 
kD n.d. G C G G U/C G A G 
          
Mut7-2 Q1126 Q1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (15) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 N1079 N1043 C1007 N971 C935 N899 S863 
kD = 6.0 nM U U U A U/C A U A 
          
R7(S
N
/YxxR) Q1126 R1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (19) 
Y1123 
N/Y 
1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 C935 N899 S863 
kD n.d. U C U A U/C A U A 
          
G2C Q1126 R1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 G1079 N1043 C1007 N971 C935 N899 S863 
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kD n.d. U C U A U/C A U A 
          
Mut6-2/7-2 = 
Var1 
Q1126 Q1083 E1047 Q1011 Q975 Q939 Q903 Q867 (15,33,53) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 N1079 S1043 C1007 N971 C935 N899 S863 
kD = 18 nM U U G A U/C A U A 
          
Mut7-2/3-1 Q1126 Q1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (15) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 N1079 N1043 C1007 N971 N935 N899 S863 
kD = 0.6 nM U U U A U/C U U A 
          
U3A Q1126 E1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 C1043 C1007 N971 C935 N899 S863 
kD n.d. U G A A U/C A U A 
          
U3G Q1126 E1083 E1047 Q1011 Q975 Q939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 S1043 C1007 N971 C935 N899 S863 
kD n.d. U G G A U/C A U A 
          
mPum2 Q1126 E1083 E1047 Q1011 Q975 Q939 Q903 Q867 (14,20) 
Y1123 N1080 N1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 S1043 C1007 N971 C935 N899 S863 
kD = 92 nM U G G A U/C A U A 
          
R6(S
Y
/HxxR) Q1126 E1083 R1047 Q1011 Q975 Q939 Q903 Q867 (19) 
Y1123 N1080 
Y/H 
1044 R1008 H972 R936 Y900 R864 
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 N1122 S1079 S1043 C1007 N971 C935 N899 S863 
kD n.d. U G C A U/C A U A 
          
U3C Q1126 E1083 R1047 Q1011 Q975 Q939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 
G/A/S/
T/C 
1043 C1007 N971 C935 N899 S863 
kD n.d. U G C A U/C A U A 
          
PUF-B Q1126 E1083 R1047 Q1011 Q975 Q939 Q903 E867 (19) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 S1043 N1007 N971 C935 N899 S863 
kD n.d. U G C U U/C A U G 
          
PUF-C Q1126 E1083 R1047 Q1011 Q975 R939 Q903 E867 (19) 
Y1123 N1080 Y1044 R1008 H972 Y936 Y900 R864 
 N1122 S1079 S1043 N1007 N971 S935 N899 S863 
kD n.d. U G C U U/C C U G 
          
mPum1 Q1126 E1083 Q1047 Q1011 S975 E939 Q903 Q867 (20) 
Y1123 N1080 N1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 C1043 N1007 N971 S935 N899 N863 
kD = 163 nM U G A U G G U U 
          
T3809 Q1126 E1083 Q1047 Q1011 Q975 E939 Q903 Q867 (24,26,27) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 C1043 N1007 C971 S935 N899 N863 
kD n.d. U G A U A G U U 
          
PUF-D Q1126 E1083 R1047 Q1011 E975 R939 Q903 E867 (19) 
 30 
Y1123 N1080 Y1044 R1008 Y972 Y936 Y900 R864 
 N1122 S1079 S1043 N1007 S971 S935 N899 S863 
kD n.d. U G C U G C U G 
          
R6/R2(SYxxR) Q1126 E1083 R1047 Q1011 Q975 Q939 R903 Q867 (19) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 S1043 C1007 N971 C935 S899 S863 
 U G C A U/C A C A 
          
PUF-A Q1126 E1083 R1047 Q1011 Q975 Q939 Q903 E867 (19) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 S1043 C1007 N971 C935 N899 S863 
kD n.d. U G C A U/C A U G 
          
R5(S
R
/YxxR) Q1126 E1083 Q1047 R1011 Q975 Q939 Q903 Q867 (19) 
Y1123 N1080 Y1044 
R/Y 
1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 S1007 N971 C935 N899 S863 
kD n.d. U G U C U/C A U A 
          
A4C Q1126 E1083 Q1047 R1011 Q975 Q939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 G1007 N971 C935 N899 S863 
kD n.d. U G U C U/C A U A 
          
actPUM2 Q1126 E1083 Q1047 E1011 Q975 Q939 E903 Q867 (23) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 C1043 S1007 N971 N935 S899 N863 
kD n.d. U G U G U/C U G U 
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mPUM4 Q1126 E1083 Q1047 E1011 Q975 E939 E903 Q867 (21) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 C1043 S1007 N971 N935 S899 N863 
kD n.d. U G U G U/C U G U 
          
T3794 Q1126 E1083 Q1047 Q1011 E975 Q939 Q903 Q867 (22,24,26,2
7) Y1123 N1080 Y1044 R1008 N972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 S971 C935 N899 S863 
kD n.d. U G U A G A U A 
          
U5C Q1126 E1083 Q1047 Q1011 R975 Q939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 G971 C935 N899 S863 
kD n.d. U G U A C A U A 
          
Mut3-1 Q1126 E1083 Q1047 Q1011 Q975 Q939 Q903 Q867 (15) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 N935 N899 S863 
kD = 0.5 nM U G U A U/C U U A 
          
Mut3-2 = 
mPUM3 
Q1126 E1083 Q1047 Q1011 Q975 E939 Q903 Q867 (15,21,53) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 S935 N899 S863 
kD = 0.05 nM U G U A U/C G U A 
          
A6C Q1126 E1083 Q1047 Q1011 Q975 R939 Q903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 G935 N899 S863 
kD n.d. U G U A U/C C U A 
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R3(SYxxR)-
Y972 
Q1126 E1083 Q1047 Q1011 Q975 R939 Q903 Q867 (19) 
Y1123 N1080 Y1044 R1008 Y972 R/Y936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 S935 N899 S863 
kD n.d. U G U A U/C C U A 
          
actPUM1 Q1126 E1083 Q1047 Q1011 Q975 E939 Q903 E867 (23) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 S935 N899 S863 
kD n.d. U G U A U/C G U G 
          
R2(SYxxR) Q1126 E1083 Q1047 Q1011 Q975 Q939 R903 Q867 (19) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 C935 S899 S863 
kD n.d. U G U A U/C A C A 
          
U7C Q1126 E1083 Q1047 Q1011 Q975 Q939 R903 Q867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 C935 G899 S863 
kD n.d. U G U A U/C A C A 
          
Mut1-1 Q1126 E1083 Q1047 Q1011 Q975 Q939 Q903 E867 (15) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 C935 N899 S863 
kD = 1.3 nM U G U A U/C A U G 
          
A8C Q1126 E1083 Q1047 Q1011 Q975 Q939 Q903 R867 (18) 
Y1123 N1080 Y1044 R1008 H972 R936 Y900 R864 
 N1122 S1079 N1043 C1007 N971 C935 N899 G863 
kD n.d. U G U A U/C A U C 
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Table 2: Oligonucleotide primers for constructing a PUM-BiFC system to image TMV RNA 
Primer name Sequence (5’→3’) 
attB-PUMfor AAAAAGCAGGCTCTAGATGGGCAGGAGCAGGCTTTTGG 
attB-PUMrev AGAAAGCTGGGTCTCGAGTTATCCCTAAGTCAACACCGTTCTTCATG 
link-PUMfor GGAGGTGGTGGATCTAGAGGCAGGAGCAGGCTTTTGG 
link-PUMrev AGATCCACCACCTCCCTCGAGTCCCTAAGTCAACACCGTTCTTCATG 
A8U_095for ACCAGCATGGGAACAGATTCATTCAG 
A8U_119rev TGAATGAATCTGTTCCCATGCTGGTC 
A6G_323for GCCGTGTTATCGAGAAAGCTCTTGAG 
A6G_333rev1 GATAACACGGCTGCCATACATCTGTAG 
A6G_333rev2 TCAAGAGCTTTCTCGATAACACGGCTGCCATACATCTGTAG 
U5G_425for ATGGCAGTAACGTGGTTGAGAAATG 
U5G_434for ACGTGGTTGAGAAATGCATTGAATGTG 
U5G_441rev AACCACGTTACTGCCATTCTGATCTTTCAC 
U5G_449rev CATTTCTCAACCACGTTACTGCCATTCTGATCTT 
U5A_416for AAGATCAGAATGGCTGTCACGTGGTTC 
U5A_440rev ACCACGTGACAGCCATTCTGATCTTTC 
A4U_527for ATCCTTATGGCAACCGAGTGATTCAG 
A4U_549rev AATCACTCGGTTGCCATAAGGATGTG 
U3A_625for CTTGTACAGGATCAATATGGATGTTATGTAATCC 
U3A_658rev GGATTACATAACATCCATATTGATCCTGTACAAG 
attB-Citfor AAAAAGCAGGCTATGGTGAGCAAGGGCGAGG 
attB-Citrev AGAAAGCTGGGTTTACTTGTACAGCTCGTCCATGCCG 
link-CitNrev TCTAGATCCACCACCTCCGTCCTCGATGTTGTGGCGGATC 
link-CitCfor CTCGAGGGAGGTGGTGGATCTGGCAGCGTGCAGCTCGC 
Citmonofor CTACCAGTCCAAACTGAGCAAAGAC 
Citmonorev GTCTTTGCTCAGTTTGGACTGGTAG 
 34 
attB1-adapter GGGGACAAGTTTGTACAAAAAAGCAGGCT 
attB2-adapter GGGGACCACTTTGTACAAGAAAGCTGGGT 
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